NXGL Stock Overview
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
NEXGEL, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.29 |
| 52 Week High | US$3.14 |
| 52 Week Low | US$1.40 |
| Beta | 0.68 |
| 1 Month Change | -16.38% |
| 3 Month Change | 3.40% |
| 1 Year Change | 42.81% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -35.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| NXGL | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 3.4% | 1.6% | 1.0% |
| 1Y | 42.8% | -1.4% | 21.9% |
Return vs Industry: NXGL exceeded the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: NXGL exceeded the US Market which returned 24.9% over the past year.
Price Volatility
| NXGL volatility | |
|---|---|
| NXGL Average Weekly Movement | 11.0% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NXGL's share price has been volatile over the past 3 months.
Volatility Over Time: NXGL's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 19 | Adam Levy | nexgel.com |
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019.
NEXGEL, Inc. Fundamentals Summary
| NXGL fundamental statistics | |
|---|---|
| Market cap | US$14.23m |
| Earnings (TTM) | -US$3.16m |
| Revenue (TTM) | US$4.09m |
3.5x
P/S Ratio-4.5x
P/E RatioIs NXGL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXGL income statement (TTM) | |
|---|---|
| Revenue | US$4.09m |
| Cost of Revenue | US$3.47m |
| Gross Profit | US$619.00k |
| Other Expenses | US$3.78m |
| Earnings | -US$3.16m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.51 |
| Gross Margin | 15.14% |
| Net Profit Margin | -77.21% |
| Debt/Equity Ratio | 16.2% |
How did NXGL perform over the long term?
See historical performance and comparison